 Dylan Taatjes
Concepts (377)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA Polymerase II | 35 | 2025 | 339 | 10.990 |
Why?
| | Mediator Complex | 27 | 2025 | 61 | 9.060 |
Why?
| | Transcription, Genetic | 42 | 2025 | 1485 | 7.260 |
Why?
| | Cyclin-Dependent Kinases | 15 | 2025 | 130 | 6.680 |
Why?
| | Transcription Factors | 30 | 2025 | 1703 | 3.830 |
Why?
| | Cyclin-Dependent Kinase 8 | 13 | 2025 | 51 | 3.310 |
Why?
| | Transcription Factor TFIIH | 9 | 2025 | 40 | 3.180 |
Why?
| | Tumor Suppressor Protein p53 | 8 | 2022 | 526 | 2.600 |
Why?
| | Gene Expression Regulation | 22 | 2025 | 2604 | 2.320 |
Why?
| | Promoter Regions, Genetic | 14 | 2025 | 1241 | 2.320 |
Why?
| | Transcription Initiation, Genetic | 6 | 2025 | 19 | 2.020 |
Why?
| | Transcription Factor TFIID | 3 | 2021 | 21 | 1.350 |
Why?
| | Transcriptional Activation | 8 | 2025 | 377 | 1.180 |
Why?
| | Multiprotein Complexes | 5 | 2017 | 171 | 1.150 |
Why?
| | Chromatin | 12 | 2022 | 533 | 1.110 |
Why?
| | Gene Regulatory Networks | 2 | 2025 | 310 | 0.950 |
Why?
| | Transcription Initiation Site | 4 | 2021 | 42 | 0.920 |
Why?
| | Protein Binding | 19 | 2024 | 2238 | 0.860 |
Why?
| | Antibiotics, Antineoplastic | 7 | 2001 | 131 | 0.830 |
Why?
| | Transcription Factors, TFII | 4 | 2015 | 44 | 0.830 |
Why?
| | Interferons | 1 | 2025 | 195 | 0.810 |
Why?
| | Cryoelectron Microscopy | 8 | 2025 | 193 | 0.780 |
Why?
| | Cell Nucleus | 7 | 2021 | 607 | 0.740 |
Why?
| | Protein Subunits | 8 | 2015 | 228 | 0.730 |
Why?
| | Saccharomyces cerevisiae | 6 | 2022 | 556 | 0.700 |
Why?
| | Saccharomyces cerevisiae Proteins | 4 | 2022 | 403 | 0.690 |
Why?
| | Trans-Activators | 6 | 2011 | 394 | 0.680 |
Why?
| | Doxorubicin | 8 | 2000 | 358 | 0.680 |
Why?
| | Protein Kinase Inhibitors | 2 | 2025 | 917 | 0.660 |
Why?
| | Humans | 73 | 2025 | 140898 | 0.650 |
Why?
| | Daunorubicin | 7 | 2000 | 24 | 0.610 |
Why?
| | Cell Proliferation | 2 | 2025 | 2497 | 0.600 |
Why?
| | Phosphorylation | 10 | 2025 | 1758 | 0.590 |
Why?
| | Drosophila | 1 | 2020 | 154 | 0.590 |
Why?
| | Signal Transduction | 8 | 2025 | 5148 | 0.580 |
Why?
| | Phosphoproteins | 2 | 2023 | 335 | 0.580 |
Why?
| | Phenanthrenes | 1 | 2018 | 12 | 0.570 |
Why?
| | Diterpenes | 1 | 2018 | 27 | 0.570 |
Why?
| | Drosophila Proteins | 1 | 2020 | 206 | 0.560 |
Why?
| | Down Syndrome | 1 | 2025 | 505 | 0.560 |
Why?
| | Molecular Biology | 1 | 2018 | 60 | 0.550 |
Why?
| | Biophysics | 1 | 2018 | 74 | 0.550 |
Why?
| | Cell Line | 9 | 2025 | 2879 | 0.530 |
Why?
| | Formaldehyde | 6 | 2000 | 65 | 0.530 |
Why?
| | Polycyclic Compounds | 2 | 2016 | 14 | 0.520 |
Why?
| | Receptors, Thyroid Hormone | 2 | 2008 | 18 | 0.510 |
Why?
| | Osteosarcoma | 1 | 2017 | 72 | 0.510 |
Why?
| | Animals | 29 | 2025 | 37579 | 0.490 |
Why?
| | Models, Biological | 3 | 2020 | 1822 | 0.490 |
Why?
| | Nucleocytoplasmic Transport Proteins | 1 | 2015 | 7 | 0.480 |
Why?
| | Porins | 1 | 2015 | 17 | 0.470 |
Why?
| | Nuclear Receptor Coactivator 3 | 1 | 2015 | 5 | 0.460 |
Why?
| | Mediator Complex Subunit 1 | 3 | 2020 | 5 | 0.460 |
Why?
| | E1A-Associated p300 Protein | 1 | 2015 | 12 | 0.460 |
Why?
| | HeLa Cells | 11 | 2019 | 639 | 0.450 |
Why?
| | RNA | 1 | 2021 | 929 | 0.440 |
Why?
| | Bone Neoplasms | 1 | 2017 | 247 | 0.440 |
Why?
| | Leiomyoma | 1 | 2015 | 56 | 0.440 |
Why?
| | Uterine Neoplasms | 1 | 2015 | 92 | 0.420 |
Why?
| | Protein Kinases | 1 | 2016 | 308 | 0.420 |
Why?
| | DNA | 7 | 2022 | 1438 | 0.410 |
Why?
| | Estrogen Receptor alpha | 1 | 2015 | 144 | 0.410 |
Why?
| | Protein Conformation | 7 | 2021 | 939 | 0.410 |
Why?
| | Protein Structure, Quaternary | 4 | 2021 | 120 | 0.400 |
Why?
| | TOR Serine-Threonine Kinases | 2 | 2013 | 428 | 0.400 |
Why?
| | Epirubicin | 4 | 2002 | 4 | 0.380 |
Why?
| | DNA Helicases | 4 | 2022 | 141 | 0.370 |
Why?
| | Antineoplastic Agents | 7 | 2020 | 2156 | 0.370 |
Why?
| | HCT116 Cells | 4 | 2021 | 80 | 0.360 |
Why?
| | Genes, p53 | 3 | 2021 | 68 | 0.360 |
Why?
| | Enzyme Activation | 3 | 2020 | 801 | 0.350 |
Why?
| | Enhancer Elements, Genetic | 5 | 2024 | 188 | 0.350 |
Why?
| | Imidazoles | 3 | 2021 | 254 | 0.320 |
Why?
| | Biophysical Phenomena | 2 | 2021 | 68 | 0.320 |
Why?
| | Histones | 3 | 2015 | 638 | 0.320 |
Why?
| | DNA Repair | 4 | 2022 | 239 | 0.310 |
Why?
| | Mass Spectrometry | 9 | 2015 | 740 | 0.300 |
Why?
| | DNA-Binding Proteins | 5 | 2021 | 1478 | 0.300 |
Why?
| | Proteomics | 1 | 2016 | 1136 | 0.300 |
Why?
| | Tumor Cells, Cultured | 8 | 2017 | 956 | 0.300 |
Why?
| | Protamine Kinase | 1 | 2008 | 8 | 0.300 |
Why?
| | Cell Cycle | 2 | 2025 | 598 | 0.290 |
Why?
| | Piperazines | 3 | 2021 | 371 | 0.290 |
Why?
| | Gene Expression Regulation, Neoplastic | 5 | 2024 | 1430 | 0.290 |
Why?
| | Models, Molecular | 8 | 2015 | 1602 | 0.290 |
Why?
| | DNA Adducts | 5 | 1999 | 16 | 0.280 |
Why?
| | Serine | 3 | 2023 | 148 | 0.270 |
Why?
| | Histone Acetyltransferases | 1 | 2008 | 63 | 0.270 |
Why?
| | Nuclear Proteins | 4 | 2020 | 716 | 0.260 |
Why?
| | Recombinant Proteins | 6 | 2020 | 1361 | 0.250 |
Why?
| | Repressor Proteins | 2 | 2014 | 428 | 0.250 |
Why?
| | Intrinsically Disordered Proteins | 2 | 2024 | 39 | 0.250 |
Why?
| | Mitochondria | 1 | 2013 | 974 | 0.250 |
Why?
| | Protein Isoforms | 2 | 2021 | 398 | 0.250 |
Why?
| | Substrate Specificity | 3 | 2023 | 384 | 0.230 |
Why?
| | Crystallography, X-Ray | 4 | 2017 | 485 | 0.230 |
Why?
| | Proteome | 2 | 2023 | 483 | 0.230 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2008 | 438 | 0.220 |
Why?
| | Escherichia coli Proteins | 2 | 2017 | 202 | 0.220 |
Why?
| | Genes, Regulator | 1 | 2004 | 36 | 0.220 |
Why?
| | Protein Structure, Tertiary | 6 | 2013 | 858 | 0.220 |
Why?
| | Receptors, Calcitriol | 1 | 2004 | 55 | 0.210 |
Why?
| | Interferon-gamma | 2 | 2019 | 789 | 0.200 |
Why?
| | Threonine | 1 | 2023 | 47 | 0.200 |
Why?
| | Drug Resistance, Neoplasm | 5 | 2020 | 832 | 0.190 |
Why?
| | Aging | 1 | 2013 | 1917 | 0.190 |
Why?
| | Yeasts | 1 | 2022 | 52 | 0.190 |
Why?
| | Escherichia coli | 2 | 2017 | 835 | 0.190 |
Why?
| | DNA, Neoplasm | 2 | 1999 | 157 | 0.180 |
Why?
| | Herpes Simplex Virus Protein Vmw65 | 3 | 2010 | 6 | 0.180 |
Why?
| | Molecular Probes | 1 | 2022 | 34 | 0.180 |
Why?
| | Tumor Suppressor Proteins | 1 | 2024 | 325 | 0.180 |
Why?
| | Sterol Regulatory Element Binding Protein 1 | 3 | 2010 | 56 | 0.180 |
Why?
| | Nucleic Acid Conformation | 5 | 2016 | 725 | 0.170 |
Why?
| | HL-60 Cells | 1 | 2020 | 33 | 0.170 |
Why?
| | Mammals | 1 | 2022 | 286 | 0.170 |
Why?
| | Carcinoma, Pancreatic Ductal | 1 | 2024 | 285 | 0.160 |
Why?
| | Fluorouracil | 1 | 2021 | 206 | 0.160 |
Why?
| | Cell Survival | 2 | 2020 | 1129 | 0.160 |
Why?
| | Software | 1 | 2025 | 676 | 0.160 |
Why?
| | Gene Knockdown Techniques | 3 | 2016 | 331 | 0.150 |
Why?
| | Positive Transcriptional Elongation Factor B | 2 | 2017 | 29 | 0.150 |
Why?
| | Protein Interaction Maps | 1 | 2019 | 49 | 0.150 |
Why?
| | Genome, Human | 1 | 2021 | 421 | 0.150 |
Why?
| | Octamer Transcription Factor-3 | 1 | 2018 | 18 | 0.150 |
Why?
| | Genetic Variation | 1 | 2004 | 994 | 0.150 |
Why?
| | Mouse Embryonic Stem Cells | 1 | 2018 | 31 | 0.150 |
Why?
| | Alternative Splicing | 1 | 2020 | 232 | 0.140 |
Why?
| | Alkylating Agents | 1 | 1998 | 24 | 0.140 |
Why?
| | Anthracyclines | 1 | 1998 | 41 | 0.140 |
Why?
| | Epoxy Compounds | 1 | 2018 | 31 | 0.140 |
Why?
| | DNA-Directed RNA Polymerases | 2 | 2025 | 63 | 0.140 |
Why?
| | Bacterial Proteins | 1 | 2004 | 910 | 0.140 |
Why?
| | RNA Splicing | 1 | 2019 | 270 | 0.140 |
Why?
| | TATA-Binding Protein Associated Factors | 1 | 2017 | 18 | 0.140 |
Why?
| | Fibroblasts | 3 | 2019 | 1017 | 0.140 |
Why?
| | STAT1 Transcription Factor | 2 | 2019 | 71 | 0.130 |
Why?
| | Mutation | 3 | 2021 | 3999 | 0.130 |
Why?
| | Drug Design | 1 | 1998 | 168 | 0.130 |
Why?
| | Biology | 1 | 2018 | 92 | 0.130 |
Why?
| | DNA-Directed DNA Polymerase | 1 | 2017 | 48 | 0.130 |
Why?
| | Cell Cycle Proteins | 4 | 2020 | 632 | 0.130 |
Why?
| | Research | 1 | 2020 | 431 | 0.130 |
Why?
| | HEK293 Cells | 5 | 2019 | 737 | 0.120 |
Why?
| | Peptides | 1 | 2022 | 979 | 0.120 |
Why?
| | DNA Damage | 1 | 2019 | 429 | 0.120 |
Why?
| | Mitosis | 1 | 2017 | 197 | 0.120 |
Why?
| | RNA, Bacterial | 1 | 2017 | 189 | 0.120 |
Why?
| | Receptors, Estrogen | 1 | 2018 | 411 | 0.120 |
Why?
| | Pancreatic Neoplasms | 1 | 2024 | 889 | 0.120 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2019 | 430 | 0.120 |
Why?
| | Genes, Neoplasm | 1 | 2015 | 22 | 0.120 |
Why?
| | Glutathione | 2 | 2013 | 362 | 0.120 |
Why?
| | DNA, Bacterial | 1 | 2017 | 333 | 0.120 |
Why?
| | Histone-Lysine N-Methyltransferase | 1 | 2017 | 134 | 0.120 |
Why?
| | Chromosomal Proteins, Non-Histone | 2 | 2020 | 124 | 0.120 |
Why?
| | Cholesterol | 1 | 2017 | 404 | 0.110 |
Why?
| | Neoplasms | 2 | 2020 | 2718 | 0.110 |
Why?
| | Alkylation | 4 | 1999 | 26 | 0.110 |
Why?
| | Transcriptome | 1 | 2021 | 1007 | 0.110 |
Why?
| | Quinine | 1 | 2014 | 21 | 0.110 |
Why?
| | Antimalarials | 1 | 2014 | 33 | 0.110 |
Why?
| | Enzyme Inhibitors | 1 | 2018 | 842 | 0.110 |
Why?
| | Antigen-Antibody Complex | 1 | 2014 | 87 | 0.110 |
Why?
| | Models, Genetic | 2 | 2011 | 587 | 0.110 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2016 | 321 | 0.110 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 2014 | 74 | 0.110 |
Why?
| | Protein Interaction Domains and Motifs | 2 | 2015 | 150 | 0.100 |
Why?
| | Membrane Potential, Mitochondrial | 1 | 2013 | 74 | 0.100 |
Why?
| | RNA, Untranslated | 1 | 2015 | 124 | 0.100 |
Why?
| | Unfolded Protein Response | 1 | 2013 | 60 | 0.100 |
Why?
| | CCAAT-Enhancer-Binding Proteins | 2 | 2004 | 37 | 0.100 |
Why?
| | SKP Cullin F-Box Protein Ligases | 1 | 2013 | 16 | 0.100 |
Why?
| | RNA-Binding Protein FUS | 1 | 2012 | 13 | 0.100 |
Why?
| | Epigenomics | 1 | 2013 | 112 | 0.100 |
Why?
| | Macromolecular Substances | 2 | 2004 | 224 | 0.100 |
Why?
| | Molecular Sequence Data | 3 | 2013 | 2917 | 0.100 |
Why?
| | Chromatography, High Pressure Liquid | 4 | 1997 | 593 | 0.090 |
Why?
| | Cell Line, Tumor | 5 | 2024 | 3487 | 0.090 |
Why?
| | Pyrococcus furiosus | 1 | 2010 | 3 | 0.080 |
Why?
| | Protein Multimerization | 1 | 2012 | 194 | 0.080 |
Why?
| | Transcription Factor TFIIB | 1 | 2010 | 13 | 0.080 |
Why?
| | Protein Biosynthesis | 1 | 2013 | 444 | 0.080 |
Why?
| | RNA, Long Noncoding | 1 | 2013 | 173 | 0.080 |
Why?
| | Archaeal Proteins | 1 | 2010 | 45 | 0.080 |
Why?
| | Amino Acid Sequence | 2 | 2013 | 2152 | 0.080 |
Why?
| | DNA, Single-Stranded | 1 | 2011 | 120 | 0.080 |
Why?
| | Biochemistry | 1 | 2010 | 36 | 0.080 |
Why?
| | Serum Response Factor | 1 | 2010 | 31 | 0.080 |
Why?
| | Molecular Dynamics Simulation | 1 | 2012 | 246 | 0.080 |
Why?
| | Telomere-Binding Proteins | 1 | 2011 | 120 | 0.080 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2010 | 103 | 0.080 |
Why?
| | Oxidation-Reduction | 3 | 1998 | 1086 | 0.080 |
Why?
| | Embryonic Stem Cells | 1 | 2010 | 129 | 0.080 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2010 | 377 | 0.080 |
Why?
| | DNA Polymerase II | 1 | 2009 | 35 | 0.070 |
Why?
| | Coenzymes | 1 | 2008 | 19 | 0.070 |
Why?
| | Pol1 Transcription Initiation Complex Proteins | 1 | 2008 | 5 | 0.070 |
Why?
| | Cell Lineage | 2 | 2024 | 351 | 0.070 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2015 | 652 | 0.070 |
Why?
| | RNA, Messenger | 1 | 2016 | 2822 | 0.070 |
Why?
| | Cyclins | 1 | 2008 | 91 | 0.070 |
Why?
| | Gene Expression | 1 | 2013 | 1490 | 0.070 |
Why?
| | In Vitro Techniques | 1 | 2010 | 1093 | 0.070 |
Why?
| | Chromatography, Liquid | 1 | 2010 | 453 | 0.070 |
Why?
| | Telomere | 1 | 2011 | 279 | 0.070 |
Why?
| | Reproducibility of Results | 1 | 2016 | 3336 | 0.070 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2008 | 136 | 0.070 |
Why?
| | Protein Processing, Post-Translational | 1 | 2010 | 463 | 0.070 |
Why?
| | Acetylation | 1 | 2008 | 245 | 0.070 |
Why?
| | Dithiothreitol | 2 | 1997 | 19 | 0.070 |
Why?
| | Protein Domains | 2 | 2019 | 303 | 0.070 |
Why?
| | Vesiculovirus | 2 | 2019 | 17 | 0.060 |
Why?
| | Mice | 7 | 2019 | 18057 | 0.060 |
Why?
| | Age Factors | 1 | 2013 | 3278 | 0.060 |
Why?
| | Microscopy, Electron | 3 | 2002 | 440 | 0.060 |
Why?
| | Hydrogen Peroxide | 2 | 1997 | 338 | 0.060 |
Why?
| | Cell Division | 2 | 2015 | 792 | 0.060 |
Why?
| | Molecular Structure | 2 | 2014 | 501 | 0.060 |
Why?
| | STAT3 Transcription Factor | 2 | 2019 | 211 | 0.060 |
Why?
| | Vitamin D Response Element | 1 | 2004 | 1 | 0.050 |
Why?
| | Sp1 Transcription Factor | 1 | 2004 | 25 | 0.050 |
Why?
| | Hydrolysis | 3 | 2002 | 196 | 0.050 |
Why?
| | Kinetics | 2 | 2016 | 1651 | 0.050 |
Why?
| | Binding Sites | 2 | 2004 | 1315 | 0.050 |
Why?
| | Phosphothreonine | 1 | 2023 | 6 | 0.050 |
Why?
| | Gene Expression Profiling | 1 | 2010 | 1761 | 0.050 |
Why?
| | Phosphoserine | 1 | 2023 | 32 | 0.050 |
Why?
| | Species Specificity | 1 | 2004 | 577 | 0.050 |
Why?
| | Datasets as Topic | 1 | 2023 | 123 | 0.050 |
Why?
| | Recombinant Fusion Proteins | 2 | 2002 | 672 | 0.050 |
Why?
| | Precipitin Tests | 1 | 2002 | 98 | 0.050 |
Why?
| | Cross-Linking Reagents | 3 | 2015 | 208 | 0.050 |
Why?
| | TATA-Box Binding Protein | 2 | 2013 | 20 | 0.050 |
Why?
| | Mutagenesis | 1 | 2022 | 182 | 0.040 |
Why?
| | Mammary Neoplasms, Experimental | 1 | 2002 | 68 | 0.040 |
Why?
| | Base Sequence | 2 | 2016 | 2169 | 0.040 |
Why?
| | Genetic Techniques | 1 | 2021 | 67 | 0.040 |
Why?
| | Oligonucleotides | 2 | 1999 | 147 | 0.040 |
Why?
| | Breast | 1 | 2021 | 155 | 0.040 |
Why?
| | Serine-Arginine Splicing Factors | 1 | 2020 | 23 | 0.040 |
Why?
| | Evolution, Molecular | 1 | 2004 | 505 | 0.040 |
Why?
| | Adenosine Triphosphatases | 1 | 2021 | 159 | 0.040 |
Why?
| | TGF-beta Superfamily Proteins | 1 | 2019 | 5 | 0.040 |
Why?
| | Receptors, Glucocorticoid | 1 | 2021 | 137 | 0.040 |
Why?
| | Smad3 Protein | 1 | 2019 | 44 | 0.040 |
Why?
| | STAT Transcription Factors | 1 | 2019 | 16 | 0.040 |
Why?
| | Tumor Suppressor p53-Binding Protein 1 | 1 | 2019 | 13 | 0.040 |
Why?
| | RNA, Neoplasm | 1 | 1999 | 79 | 0.040 |
Why?
| | Immunoglobulin G | 2 | 2014 | 897 | 0.040 |
Why?
| | RNA Splicing Factors | 1 | 2019 | 57 | 0.040 |
Why?
| | Radiation, Ionizing | 1 | 2019 | 80 | 0.040 |
Why?
| | Models, Chemical | 2 | 1997 | 272 | 0.040 |
Why?
| | Spectrometry, Fluorescence | 1 | 1999 | 167 | 0.040 |
Why?
| | Dexamethasone | 1 | 2021 | 379 | 0.040 |
Why?
| | Green Fluorescent Proteins | 1 | 2020 | 401 | 0.040 |
Why?
| | Adenosine Triphosphate | 1 | 2021 | 490 | 0.040 |
Why?
| | Imaging, Three-Dimensional | 1 | 2002 | 566 | 0.030 |
Why?
| | Chemistry, Pharmaceutical | 1 | 1998 | 106 | 0.030 |
Why?
| | Drug Carriers | 1 | 1999 | 127 | 0.030 |
Why?
| | Microscopy, Atomic Force | 2 | 2014 | 128 | 0.030 |
Why?
| | Buffers | 1 | 1997 | 56 | 0.030 |
Why?
| | Synaptic Vesicles | 1 | 1998 | 41 | 0.030 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2019 | 175 | 0.030 |
Why?
| | Anaerobiosis | 1 | 1997 | 65 | 0.030 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 1998 | 191 | 0.030 |
Why?
| | Wnt Signaling Pathway | 1 | 2019 | 202 | 0.030 |
Why?
| | Indicators and Reagents | 1 | 1997 | 110 | 0.030 |
Why?
| | Oxazoles | 1 | 1997 | 46 | 0.030 |
Why?
| | Breast Neoplasms | 2 | 2000 | 2235 | 0.030 |
Why?
| | Nucleic Acids | 1 | 1998 | 70 | 0.030 |
Why?
| | Xanthine Oxidase | 1 | 1997 | 81 | 0.030 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2002 | 771 | 0.030 |
Why?
| | beta Catenin | 1 | 2019 | 258 | 0.030 |
Why?
| | NAD | 1 | 1997 | 78 | 0.030 |
Why?
| | Uridine Triphosphate | 1 | 2016 | 10 | 0.030 |
Why?
| | Sulfhydryl Reagents | 1 | 1996 | 12 | 0.030 |
Why?
| | Spectrophotometry, Ultraviolet | 1 | 1996 | 85 | 0.030 |
Why?
| | Fluorescence | 1 | 2017 | 161 | 0.030 |
Why?
| | Hydrogen-Ion Concentration | 1 | 1998 | 556 | 0.030 |
Why?
| | Guanosine Triphosphate | 1 | 2016 | 87 | 0.030 |
Why?
| | Nerve Tissue Proteins | 2 | 1998 | 605 | 0.030 |
Why?
| | Computer Simulation | 1 | 2021 | 1011 | 0.030 |
Why?
| | Immunologic Techniques | 2 | 2014 | 39 | 0.030 |
Why?
| | Computational Biology | 1 | 2021 | 664 | 0.030 |
Why?
| | Host-Pathogen Interactions | 1 | 2019 | 370 | 0.030 |
Why?
| | Oxidants | 1 | 1996 | 111 | 0.030 |
Why?
| | Sequence Alignment | 1 | 2016 | 363 | 0.030 |
Why?
| | Xeroderma Pigmentosum Group D Protein | 1 | 2015 | 6 | 0.030 |
Why?
| | Xeroderma Pigmentosum | 1 | 2015 | 8 | 0.030 |
Why?
| | Heterocyclic Compounds, 4 or More Rings | 1 | 2015 | 19 | 0.030 |
Why?
| | Female | 5 | 2021 | 75540 | 0.030 |
Why?
| | Chromaffin Granules | 1 | 1995 | 3 | 0.030 |
Why?
| | Adrenal Medulla | 1 | 1995 | 9 | 0.030 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 1998 | 614 | 0.030 |
Why?
| | Genes, Tumor Suppressor | 1 | 2015 | 84 | 0.030 |
Why?
| | Iron | 1 | 1997 | 323 | 0.030 |
Why?
| | Mice, Inbred Strains | 1 | 2015 | 412 | 0.030 |
Why?
| | Flow Cytometry | 1 | 1999 | 1195 | 0.030 |
Why?
| | beta 2-Glycoprotein I | 1 | 2014 | 5 | 0.030 |
Why?
| | Epithelial Cells | 1 | 2021 | 1113 | 0.030 |
Why?
| | Heat Shock Transcription Factors | 1 | 2014 | 18 | 0.030 |
Why?
| | DNA-Activated Protein Kinase | 1 | 2014 | 16 | 0.030 |
Why?
| | Mice, SCID | 1 | 2015 | 365 | 0.030 |
Why?
| | GTP Phosphohydrolases | 1 | 1995 | 93 | 0.030 |
Why?
| | Antibodies, Antiphospholipid | 1 | 2014 | 21 | 0.030 |
Why?
| | Tripartite Motif-Containing Protein 28 | 1 | 2014 | 18 | 0.030 |
Why?
| | Cytoplasmic Granules | 1 | 1995 | 93 | 0.030 |
Why?
| | GTP-Binding Proteins | 1 | 1995 | 151 | 0.030 |
Why?
| | Ataxia Telangiectasia Mutated Proteins | 1 | 2014 | 70 | 0.030 |
Why?
| | Hydroxychloroquine | 1 | 2014 | 57 | 0.030 |
Why?
| | Agenesis of Corpus Callosum | 1 | 2013 | 13 | 0.020 |
Why?
| | Down-Regulation | 1 | 2015 | 638 | 0.020 |
Why?
| | Muscle Hypotonia | 1 | 2013 | 33 | 0.020 |
Why?
| | Hep G2 Cells | 1 | 2013 | 71 | 0.020 |
Why?
| | Anus, Imperforate | 1 | 2013 | 24 | 0.020 |
Why?
| | STAT5 Transcription Factor | 1 | 2013 | 56 | 0.020 |
Why?
| | Phospholipids | 1 | 2014 | 221 | 0.020 |
Why?
| | Molecular Conformation | 1 | 2013 | 147 | 0.020 |
Why?
| | Ubiquitination | 1 | 2013 | 107 | 0.020 |
Why?
| | Up-Regulation | 1 | 2015 | 856 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2019 | 3064 | 0.020 |
Why?
| | Genes, Reporter | 1 | 2013 | 272 | 0.020 |
Why?
| | Proteolysis | 1 | 2013 | 173 | 0.020 |
Why?
| | Constipation | 1 | 2013 | 96 | 0.020 |
Why?
| | Membrane Proteins | 1 | 1998 | 1156 | 0.020 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2011 | 87 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2013 | 757 | 0.020 |
Why?
| | DNA, Archaeal | 1 | 2010 | 17 | 0.020 |
Why?
| | Serum Response Element | 1 | 2010 | 6 | 0.020 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2010 | 156 | 0.020 |
Why?
| | Organ Specificity | 1 | 2010 | 311 | 0.020 |
Why?
| | Transcription Factor AP-1 | 1 | 2010 | 88 | 0.020 |
Why?
| | Protein Structure, Secondary | 1 | 2010 | 368 | 0.020 |
Why?
| | Protein Interaction Mapping | 1 | 2010 | 103 | 0.020 |
Why?
| | RNA-Binding Proteins | 1 | 2013 | 447 | 0.020 |
Why?
| | Neurons | 1 | 1998 | 1615 | 0.020 |
Why?
| | Interleukin-6 | 1 | 2013 | 777 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2019 | 5895 | 0.020 |
Why?
| | Blotting, Western | 1 | 2011 | 1231 | 0.020 |
Why?
| | Disease Progression | 1 | 2015 | 2791 | 0.020 |
Why?
| | Cells, Cultured | 2 | 2010 | 4199 | 0.020 |
Why?
| | Sialic Acids | 1 | 1985 | 8 | 0.020 |
Why?
| | Sialyltransferases | 1 | 1985 | 13 | 0.020 |
Why?
| | Transferases | 1 | 1985 | 26 | 0.010 |
Why?
| | Golgi Apparatus | 1 | 1985 | 100 | 0.010 |
Why?
| | Glutathione Transferase | 1 | 2002 | 101 | 0.010 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2002 | 335 | 0.010 |
Why?
| | Immunoblotting | 1 | 2002 | 309 | 0.010 |
Why?
| | Rats | 3 | 1998 | 5594 | 0.010 |
Why?
| | Ligands | 1 | 2002 | 667 | 0.010 |
Why?
| | Cell Death | 1 | 2002 | 387 | 0.010 |
Why?
| | Male | 2 | 2015 | 69893 | 0.010 |
Why?
| | Intercalating Agents | 1 | 1999 | 5 | 0.010 |
Why?
| | Tissue Distribution | 1 | 1999 | 327 | 0.010 |
Why?
| | R-SNARE Proteins | 1 | 1998 | 19 | 0.010 |
Why?
| | Synaptosomal-Associated Protein 25 | 1 | 1998 | 25 | 0.010 |
Why?
| | Qa-SNARE Proteins | 1 | 1998 | 20 | 0.010 |
Why?
| | Dimerization | 1 | 1997 | 195 | 0.010 |
Why?
| | Catalysis | 1 | 1997 | 320 | 0.010 |
Why?
| | rab3 GTP-Binding Proteins | 1 | 1995 | 4 | 0.010 |
Why?
| | Hemagglutinins, Viral | 1 | 1995 | 7 | 0.010 |
Why?
| | PC12 Cells | 1 | 1995 | 40 | 0.010 |
Why?
| | Microscopy, Immunoelectron | 1 | 1995 | 45 | 0.010 |
Why?
| | Hemagglutinin Glycoproteins, Influenza Virus | 1 | 1995 | 25 | 0.010 |
Why?
| | Immunoenzyme Techniques | 1 | 1995 | 207 | 0.010 |
Why?
| | Fluorescent Antibody Technique | 1 | 1995 | 386 | 0.010 |
Why?
| | Cell Membrane | 1 | 1998 | 720 | 0.010 |
Why?
| | Genetic Vectors | 1 | 1995 | 336 | 0.010 |
Why?
| | Transfection | 1 | 1995 | 936 | 0.010 |
Why?
| | Cattle | 1 | 1995 | 991 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 1998 | 2522 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2002 | 4407 | 0.010 |
Why?
| | Thiamine Pyrophosphatase | 1 | 1985 | 1 | 0.000 |
Why?
| | Nucleotidases | 1 | 1985 | 7 | 0.000 |
Why?
| | Glycoproteins | 1 | 1985 | 358 | 0.000 |
Why?
| | Liver | 1 | 1985 | 1815 | 0.000 |
Why?
|
|
Taatjes's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|